Published in Volume 114, Issue 4
J. Clin. Invest.
114(4):
598-598 (2004).
doi:10.1172/JCI20864E1.
Copyright © 2004, The American Society for Clinical Investigation
Erratum
A disintegrin-metalloproteinase prevents amyloid plaque formation and
hippocampal defects in an Alzheimer disease mouse model
Rolf Postina,
Anja Schroeder,
Ilse Dewachter,
Juergen Bohl,
Ulrich Schmitt,
Elzbieta Kojiro,
Claudia Prinzen,
Kristina Endres,
Christoph Hiemke,
Manfred Blessing,
Pascaline Flamez,
Antoine Dequenne,
Emile Godaux,
Fred van Leuven and
Falk Fahrenholz
Original citation: J. Clin. Invest.113:1456–1464(2004). doi:10.1172/JCI20864.
Citation for this Corrigendum: J. Clin. Invest.114:142 (2004). doi:10.1172/JCI20864E1.
During the preparation of this manuscript for publication, an error was introduced into
the Results section, in the fourth sentence of the paragraph beginning with
“The levels of the APP-derived soluble peptides Aβ40 and
Aβ42 in brains of double-transgenic mice and
APP[V717I] control animals
at the age of 18 weeks were quantified by specific sandwich ELISAs.” The
correct sentence appears below. We regret this error.
In line ADAM10-mo ×
APP[V717I], Aβ40
and Aβ42 were reduced by 49% and 20%, and in line
ADAM10-hi ×
APP[V717I], by
39% and 29%, respectively.
